Trending...
- From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
- Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
Dementia Specialist, Dr. Jeffrey Gelblum, Expands the Infusion Center in his Jupiter Neurology Office.
JUPITER, Fla. - PennZone -- To accommodate the exploding need for neurology services in Palm Beach, Martin, and St. Lucie counties, Jupiter Neurologist, Dr. Jeff Gelblum, proudly announces the expansion of his in-office infusion center located at 601 University Boulevard, Suite 102, in Jupiter, Florida.
Dr. Gelblum observes that an explosion of newly approved IV therapies for the treatment of Alzheimer's, MS, myasthenia gravis, and migraine warrant his center's increased capacity for IV treatment.
"Our Jupiter Infusion Center had been running at full capacity, and with the approval of even more disease-modifying treatments for severe neurologic conditions, we are now poised to meet the growing needs of our tri-county clientele," states Dr. Gelblum.
The infusion center accepts most insurances and eagerly welcomes referrals from all physicians and specialists in the community, including rheumatologists and other neurologists.
More on The PennZone
He concludes, "Our state-of-the-art neurology practice provides this area with top-notch clinical, diagnostic, and infusion care. As our community grows, we are dedicated to fulfilling the growing expectations of our patients and colleagues."
About Jeffrey Gelblum, MD, FAAN
Dr. Jeffrey Gelblum is a board-certified neurologist with offices in Aventura and Jupiter, Florida. He has successfully treated thousands of patients over 25 years, from South Florida and worldwide. He is considered a global thought leader in the neurologic treatment of dementia, seizure disorders, Parkinson's, Diabetic and Peripheral Nerve Disorder, Covid Long-Hauler, trauma, chronic pain, and more. He has hosted educational symposia in the U.S. and overseas.
Dr. Gelblum maintains numerous research FDA-sponsored affiliations, providing patients immediate access to promising new treatment protocols. He is active in multiple community outreach programs to educate the public regarding the care and treatment of neurologic disorders.
Learn more about Dr. Gelblum at https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
Dr. Gelblum observes that an explosion of newly approved IV therapies for the treatment of Alzheimer's, MS, myasthenia gravis, and migraine warrant his center's increased capacity for IV treatment.
"Our Jupiter Infusion Center had been running at full capacity, and with the approval of even more disease-modifying treatments for severe neurologic conditions, we are now poised to meet the growing needs of our tri-county clientele," states Dr. Gelblum.
The infusion center accepts most insurances and eagerly welcomes referrals from all physicians and specialists in the community, including rheumatologists and other neurologists.
More on The PennZone
- Lewis County Hydrogen Alliance Launches Phase 1 Work to Turn Forest Residuals into Fuel-Grade Hydrogen and Dispatchable Clean Power
- Next Gen Fibre Selects netElastic vBNG and CGNAT to Fuel Rapid Nationwide Expansion and Eliminate Network Bottlenecks
- Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
- 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne
- Scott G. Hoy of Hoy Law Earns 11th Consecutive Super Lawyers Selection
He concludes, "Our state-of-the-art neurology practice provides this area with top-notch clinical, diagnostic, and infusion care. As our community grows, we are dedicated to fulfilling the growing expectations of our patients and colleagues."
About Jeffrey Gelblum, MD, FAAN
Dr. Jeffrey Gelblum is a board-certified neurologist with offices in Aventura and Jupiter, Florida. He has successfully treated thousands of patients over 25 years, from South Florida and worldwide. He is considered a global thought leader in the neurologic treatment of dementia, seizure disorders, Parkinson's, Diabetic and Peripheral Nerve Disorder, Covid Long-Hauler, trauma, chronic pain, and more. He has hosted educational symposia in the U.S. and overseas.
Dr. Gelblum maintains numerous research FDA-sponsored affiliations, providing patients immediate access to promising new treatment protocols. He is active in multiple community outreach programs to educate the public regarding the care and treatment of neurologic disorders.
Learn more about Dr. Gelblum at https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
Source: First Choice Neurology
0 Comments
Latest on The PennZone
- Crossroads4Hope Announces The Lipschutz Women's Fund
- AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
- 91 Per Cent of Enterprises Will Increase AI Spending. Most Can't See the Cost — or the Risk!
- Harrisburg's newest restaurant, Eleve, sells out entire inventory during Grand Opening
- New ProEssentials v11: Native WinUI Charting Library, 100M Points in 15ms, Following Microsoft's Vision for True Native Swap-Chain Rendering
- New AI Customer Segmentation Guide Warns Marketers Not to Confuse Technical Precision With Business Value
- Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
- Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
- What's New in Hokkaido, Autumn 2026
- CRG Awarded NASA SEWP VI Contracts in Categories B and C
- Heidi G. Villari of The Villari Firm, PLLC Named to Super Lawyers for the Tenth Consecutive Year
- Elevate Your Sneakers With Crep Protect Trek Laces
- Meet Privateer: Tucson's High-Tech Security Force Built With Paramilitary Precision
- Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
- From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
- SKRAP Finds Hope Through Heartache on Powerful New Single "Shellshock"
- CodesClue: A Trusted AI-Based Software Development Company for Global Businesses
- U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
- Valgar LLC Launches The Briefing Room: Education Leaders